LINC00601

Across TCGA pan-cancer cohorts, LINC00601 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC00601 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC00601 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00601 expression acts as an unfavorable survival marker, although some lineages such as UCS and LAML show a favorable association.

STAD, MESO, and LUAD are the cancer types where LINC00601 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.265	0.672	.003	95	view →
MESO	OS	Median	II,III,IV	0.270	0.511	<.001	91	view →
LUAD	DFS	Tertile	III,IV	0.290	0.544	<.001	87	view →
ACC	OS	Tertile	All	0.684	0.913	<.001	81	view →
UCEC	OS	Tertile	All	0.549	0.706	.003	56	view →
LGG	DFS	Median	All	0.628	0.832	<.001	54	view →
KIRC	DFS	Quartile	All	0.518	0.665	<.001	49	view →
BLCA	DFS	Quartile	All	0.387	0.616	.006	38	view →
UCS	DFS	Tertile	II,III,IV	0.541	0.134	.005	36	view →
LIHC	OS	Tertile	All	0.667	0.818	.003	34	view →
LAML	DFS	Tertile	All	0.758	0.352	.041	24	view →
HNSC	DFS	Quartile	All	0.604	0.732	.006	20	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC00601–STAD (OS)

Open the STAD breakdown →